A comparison of US and Norwegian regulation of coumarin in tobacco products

Tobacco Control

Volumn 12, Issue 4, 2003, Pages 401-405

  Givel, M ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COUMARIN;

ARTICLE; ASSERTIVENESS; INDIA; INTERPERSONAL COMMUNICATION; LAW ENFORCEMENT; NORWAY; STATISTICAL SIGNIFICANCE; TOBACCO; TOBACCO INDUSTRY; UNITED STATES;

COUMARINS; HEALTH POLICY; HUMANS; NORWAY; SMOKING; TOBACCO; TOBACCO INDUSTRY; UNITED STATES;

EID: 7544242327     PISSN: 09644563     EISSN: None     Source Type: Journal    
DOI: 10.1136/tc.12.4.401     Document Type: Article

References (73)

1. Jacobs M. The toxicity of coumarin. The American Perfumer and Essential Oil Review 1953:53-6.
2. Wartman WB. Dolcourin, a coumarin substitute. American Tobacco Company document produced in the case of: State of Minnesota, et al, v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District Minnesota. Minneapolis: Minnesota Tobacco Document Depository; 3 June 1963. Bates No. ATX02 0004970.
3. Stepka W. Toxicology of coumarin. American Tobacco Company legal document produced in the case of: State of Minnesota, et al, v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District Minnesota. Minneapolis: Minnesota Tobacco Depository; 3 September 1964. Bates No. MNAT00789559-9562.
4. Tobacco Reporter. Coumarin - not good for rats but man uses it differently. Philip Morris legal document produced in the case of: State of Minnesota, et al, v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District Minnesota. Minneapolis: Minnesota Tobacco Depository; June 1969. Bates No. 2000778146-8148.
5. Palmer A, Ikeda RM, Daylor FL. Coumarin in U.S. cigarettes. Philip Morris legal document produced in the case of: State of Minnesota, et al, v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District Minnesota. Minneapolis: Minnesota Tobacco Depository; 8 February 1983. Bates No. 1003180427-0437.
6. Kohler H. Die Beeinflussung Der Grossen Korperfunctionen Durch Coumarin. Centralblatt fur die Medicinischen Wissenschaften 1875;13:867.
7. Kohler H. Eine Thatsachliche Berichtigung Die Vaguslahmende Wirkung Des Cumarins Betreffend. Archiv Fur Experimentelle Pathologie u. Pharmakologie 1877;6:283.
8. Harnack, Witkowski L. Pharmakologische Unterauchungen Uber Das Physostigmen and Calabarin. Archiv Fur Experimentelle Pathologie u Pharmakologie 1876;5:429.
9. Ellinger A. Zur Pharmakodynamischen-dynamischen Charakterisierung Des Cumarins. Archiv Fur Expermintelle Pathologie u. Pharmakologie Suppl. hd. 1908:150.
10. Bergstrom E. Action De La Cumarine Sur Le Systeme Nerveux Autonome. Comptes Rendus Des Saeances De La Sociaetae De Biologie et de Ses Filiales 1925;93:1159-62.
11. Bergstrom E. Recherches Sur Les Proprietes Pharmacologiques Du Coumarin A L'egard Des Organes Isoles Et Mainenus En Survie. Scandinavisches Archiv Fur Physiologie 1928;53:236.
12. Campos FAdM. Contribuicao Ao Estudo Da Accao Pharmacologiea Da Fava Tonka Sobre Systema Muscular. Rev. Flora Med (Rio de Janeiro) 1935;1:558.
13. Campos FAdM. "Curarization" by coumarin from tonka bean: effect of coumarin on muscular excitability. Annaes (Faculdade de Medicina Universidade de Sao Paulo) 1935;11:165.
14. Marolda CI. Contribucion al Estudio Farmacodinamico Del Octanol; Accion Sobre El Sistema Circulatorio. Revista de la Association Medica Argentina 1936;49:1567.
15. Rai K. Cumarin. Folia Pharmacologica Japanonica 1935;21:86.
16. Chen KK, Steldt F, Fried J, et al. The action of simple lactones related to cardiac aglycones. J Pharm Expl Ther 1942;74:381.
17. Giarman NJ. Antibiotic lactones and synthetic analogs. J Pharm Expl Ther 1948;94:232.
18. Giarman NJ. Antibiotic lactones and synthetic analogs II. Cardiotic effects on the isolated frog heart. J Pharm Expl Ther 1949;96:119.
19. Walton RP, Cotten M, McCord WM. Absence of digitalis-like cardiac effects in the action pattern of several simple lactones. Proc Soc Exp Biol Med 1950;74:548.
20. Hazelton LW, Tusing TW, Zeitlin BR, et al. Toxicity of coumarin. J Pharm Expl Ther 1956;118:348-59.
21. Hoffmann D, Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health 1997;50:307-64.
22. Bell JAE, Laing DH. Thermodynamic and kinetic variables in tobacco pyrolysis and their influence on their relationship between smoking and health. British American Tobacco Document. San Francisco: University of California - San Francisco; 5 November 1999.
23. Stanfill SB, Calafat AM, Brown CR, et al. Concentration of nine alkenylbenzenes, coumarin, piperonal, and pulegone in Indian bidi cigarette tobacco. Food and Chemical Toxicology 2003;41:303-17.
24. Vorhees D, Heiger-Bernays W, McClean M. Human health risk associated with cigarette smoke: the link between smoke constituents and additives. Boston: The Medical Foundation, 1997.
25. Christakopoulos A, Feldhusen K, Norin H, et al. Determination of natural levels of coumarin in different types of tobacco using a mass fragmentographic Method. Journal of Agricultural Food Chemistry 1992;40:1358-61.
26. Feuer G. The metabolism and biological action of coumarins. Amsterdam: North Holland Publishing Company, 1974.
27. Malewski A. De Camphora, Carbone Sesquichlorato, Cumarino, Vanillique Meletemata [Dissertation]: Dorpat; 1855.
28. Berkanda B, Bouffard-Eyuboglu H, Derman U. The effect of coumarin derivatives on the immunological system of man. Agents and Actions 1983;13:50-2.
29. Watson D. Coumarin. Philip Morris legal document produced in the case of: State of Minnesota, et al, v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; 16 April 1981. Bates No. 2001307135.
30. Rylander MR. The toxicology of coumarin. Philip Morris legal document produced in the case of: State of Minnesota, et al, v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; 7 September 1981. Bates No. 2023180836-2023180872.
31. Naesheim S. Coumarin in tobacco. Norwegian Directorate for Health and Social Welfare, Department for Tobacco Control, 2002.
32. Dulles F. Norway-Coumarin. Philip Morris legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 2501046311A, 11 March 1987.
33. Waterman WB. Dolcourin, a coumarin substitute American Tobacco Company legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. MNAT00576924. 7 June 1963.
34. Seligman RB. Coumarin in tobacco. Philip Morris legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 2057143630, 30 October 1969.
35. Campaign for Tobacco Free Kids. Wigand is asked whether Brown & Williamson used rat poison in pipe tobacco; 1995.
36. Wigand JS. Statement of Jeffrey S. Wigand, Ph.D., President of Smoke-Free Kids. In: Public hearings for the Framework Convention on Tobacco Control. Geneva: World Health Organization; 2000.
37. Reynolds RJ. Tobacco Company. Statement on Coumarin. R. J. Reynolds legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No 51711 9527, 1995.
38. Mintz J. Low tar, high risk. Mother Jones 1983:54-6.
39. Kurtz H. Details of unaired tobacco story emerge; cigarette firm ex-official told CBS of cancer causing flavor. Washington Post. 18 November 1995: Sect. A03.
40. Nye A. Assessment of the use of coumarin as an additive in pipe tobacco. Brown & Williamson legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 503208436-503208452, November 1990.
41. Suber R. Tonka beans and PBS documentary. RJ Reynolds legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 51742 8707. 13 March 1996.
42. Philip Morris O. Project Coumarin - Top Secret. Philip Morris legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minnesota; Bates No. 2501046314-6317. 16 March 1987.
43. Robinson JB. Norway. Philip Morris legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 2501046311A-6312. 11 March 1987.
44. Ware K. Coumarin. Philip Morris legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 2501046313A. 18 March 1987.
45. National Association of Attorneys General. Master Settlement Agreement; 2002.
46. Lake B, Gray T, Evans J, et al. Studies on mechanisms of coumarin induced toxicity in rat hepatocytes: comparison with dihydrocomarin and other coumarin metabolites. Toxicol Applied Pharmacol 1989;97:311-23.
47. Leahy RL. Notes on coumarin hearing - September 15, 1953. Philip Morris legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 2022239064. 17 September 1953.
48. United States Food and Drug Administration. FDA statements of general policy and interpretation. Washington DC: FDA, 1954.
49. Evers HH. Letter to Brown & Williamson Tobacco Company from British American Tobacco Company. Brown & Williamson legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 650203426. 29 March 1954.
50. Resnik FE. Coumarin in commercial cigarettes, Philip Morris legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 2060535675-5677. 11 November 1965.
51. Cohen MB. Production request for Philip Morris Commander cigarettes with and without coumarin project 8205, study CIN-1. Philip Morris legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 1001892964-2965. 30 January 1969.
52. Harlow ES. Status of coumarin research. American Tobacco Company legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. MNAT00789564-9565. 24 September 1964.
53. Dunn WL. Plans for evaluation of coumarin. Philip Morris legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 1000849818. 8 January 1964.
54. Seligman RB. Coumarin substitute. Philip Morris legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 1001888943. 6 September 1968.
55. Kounnas CN, Vinals JF. Elimination and/or replacement of coumarin/coumarin. Philip Morris legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al. No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 1001887929-7930. 5 February 1970.
56. Daylor FL. Coumarin. Philip Morris legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 2000759709. 20 April 1970.
57. Seligman RB. Status of coumarin (CF) in Philip Morris' tobacco products. Philip Morris legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 2022208575. 21 July 1972.
58. Resnik FE. Removal of CF. Philip Morris legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 1003722157. 16 June 1976.
59. American Tobacco Company. Coumarin content, market lot cigarettes 1982. American Tobacco Company legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. MNAT00683417/3418. 29 December 1982.
60. Cummins K. Additive adds to mystery to risk of smoking. Florida Times Union. 12 January 1983:Sect A1-2.
61. Schmid R. Questions go unanswered. Associated Press, 12 January 1983.
62. Cummins K. Cigarette makers slow to give list of all additives. Florida Times Union. 17 January 1983.
63. RJ Reynolds Tobacco Company. Coumarin (91-64-5). R. J. Reynolds legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 520991437-1443. 4 March 1998.
64. Daylor FL, Taylor BG. Coumarin. Philip Morris legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 2000777452-7453. 26 July 1985.
65. Wendelboe F. Coumarin in Golden American cigarettes R. J. Reynolds legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; Bates No. 51218 0753. 21 January 1991.
66. Mike Moore, et al. vs. American Tobacco Company, et al. Case No. 94-1429. Chancery Court of Jackson County, Mississippi, 1994.
67. Relating to Prevention of the Harmful Effects of Tobacco; 1973.
68. Danielsen P. TOP SECRET. Philip Morris legal document produced in the case of: State of Minnesota, et al. v. Philip Morris, Inc. et al., No. C1-94-8565, 2nd District, Minnesota. Minneapolis: Minnesota Tobacco Depository; 16 March 1987. Bates No. 2501046314-6317.
69. James A. Will not keep to poison deadline. The Norway Post, 10 August 1999.
70. European Commission. Directive 2001/37/EC of the European Parliament and of the Council of 5 June 2001 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco products - Commission statement. 32001L0037;2001.
71. Philip Morris, et al vs. Thomas Reilly, Attorney General of Massachusetts Case Numbers: No.00-2449 and No.00-2425. In: United States Codes Annotated: United States Court of Appeals for the First Circuit; 2002.
72. Garner BA. Black's law dictionary. Deluxe, 7th ed: West Group; 1999.
73. Givel M, Glantz S. Tobacco lobby political influence on US state legislatures in the 1990s. Tobacco Control 2000;10:124-34.